Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 9:09 PM
Ignite Modification Date:
2025-12-24 @ 9:09 PM
NCT ID:
NCT03683004
Eligibility Criteria:
Inclusion Criteria:
CRC adenocarcinoma patients:
* Stage II/IV patients receiving adjuvant CTX (Ctx+ group)
* Stage I/III patients not receiving CTX (Ctx- group)
* Normal or corrected to normal vision (corrected far visual acuity of 20/50 or better)
For demographically-matched healthy controls (HC group)
* Matched to patient receiving CTX on demographics: age (plus or minus 5 years, gender, race, menopausal status, and education (plus or minus 2 years)
* Normal or corrected-to-normal vision (corrected far visual acuity of 20/50 or better)
Exclusion Criteria:
CRC patients:
Cancer diagnosis/treatment in last 3 yrs. in addition to CRC (exceptionpatients with localized skin cancer) Prior chemotherapy within 1 year for CRC Cognitive impairment (MMSE score \< 25) prior to baseline assessment
Demographically-matched healthy controls:
CRC cancer diagnosis All exclusion criteria for CRC patients.
Healthy Volunteers:
True
Sex:
ALL
Minimum Age:
19 Years
Study:
NCT03683004
Study Brief:
Protocol Section:
NCT03683004